Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target

GK Barik, O Sahay, D Paul, MK Santra - Biochimica et Biophysica Acta …, 2022 - Elsevier
Cancer metastasis is the primary cause of morbidity and mortality in cancer as it remains the
most complicated, devastating, and enigmatic aspect of cancer. Several decades of …

Prognostic significance of serum alkaline phosphatase level in osteosarcoma: a meta‐analysis of published data

HY Ren, LL Sun, HY Li, ZM Ye - BioMed research international, 2015 - Wiley Online Library
Background. Serum alkaline phosphatase (SALP) is commonly elevated in osteosarcoma
patients. A number of studies have investigated the prognostic role of SALP level in patients …

Prognostic and predictive biomarkers of canine osteosarcoma

GT Selvarajah, J Kirpensteijn - The veterinary journal, 2010 - Elsevier
Canine osteosarcoma (OS) is an aggressive tumour that accounts for approximately 90% of
primary bone tumours in the dog. Although the standard treatments (including limb …

17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin

S Zheng, J Huang, K Zhou, C Zhang, Q Xiang, Z Tan… - PloS one, 2011 - journals.plos.org
Estrogen promotes breast cancer metastasis. However, the detailed mechanism remains
largely unknown. The actin binding protein ezrin is a key component in tumor metastasis …

Prognostic value of ezrin in various cancers: a systematic review and updated meta-analysis

J Li, K Wei, H Yu, D Jin, G Wang, B Yu - Scientific reports, 2015 - nature.com
More and more studies have investigated the effects of Ezrin expression level on the
prognostic role in various tumors. However, the results remain controversial rather than …

Mass Spectrometric-based proteomics for Biomarker Discovery in Osteosarcoma: current status and future direction

N Sirikaew, D Pruksakorn, P Chaiyawat… - International Journal of …, 2022 - mdpi.com
Due to a lack of novel therapies and biomarkers, the clinical outcomes of osteosarcoma
patients have not significantly improved for decades. The advancement of mass …

YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma

F de Nigris, L Zanella, F Cacciatore, AD Chiara… - BMC cancer, 2011 - Springer
Background The polycomb transcription factor Yin Yang 1 (YY1) overexpression can be
causally implicated in experimental tumor growth and metastasization. To date, there is no …

Osteosarcoma-specific genes as a diagnostic tool and clinical predictor of tumor progression

P Sittiju, P Chaiyawat, D Pruksakorn, J Klangjorhor… - Biology, 2022 - mdpi.com
Simple Summary The standard method for the diagnosis and monitoring of osteosarcoma is
biopsy and tumor imaging, which causes discomfort to patients and is difficult to repeat. A …

High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients

R Zhang, S Zhang, R Xing, Q Zhang - Thoracic cancer, 2019 - Wiley Online Library
Background To evaluate the EZR (ezrin) gene expression in breast cancer and correlation
with the prognosis through bioinformatics analysis and immunohistochemistry assay …

Alteration of WWOX in human cancer, a clinical view

I Baryła, E Styczeń-Binkowska… - … Biology and Medicine, 2015 - journals.sagepub.com
WWOX gene is located in FRA16D, the highly affected chromosomal fragile site. Its tumor
suppressor activity has been proposed on a basis of numerous genomic alterations reported …